MENU
RGNX
AS OF
Jan 14, 04:14 PM (EDT)
Price
$14.87
Change
-$0.19 (-1.26%)
Capitalization
761.88M
48 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

REGENXBIO (RGNX) Ownership - Who owns REGENXBIO?

Regenxbio Inc is a biotechnology company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
761.88M
P/E Ratio
N/A
Total Cash
274.21M
Projected Growth
N/A
Total Debt
76.51M
Revenue
161.32M
Risk (Beta)
2.08
Dividend Yield
N/A
Total Cash/Share
5.42
Total Debt/Equity
N/A
Revenue/Share
3.14 USD as % of share price

Fundamentals

RGNX
Capitalization
762M
P/E Ratio
N/A
Risk (Beta)
2.08
Dividend Yield
N/A
Total Cash
274M
Total Cash/Share
5.42
Total Debt
76.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.14%
Revenue
161M
ROE
N/A
Book Value
161M
P/B Ratio
4.72
Cash Flow
N/A
Earnings
-3.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
2.66
Current Revenue Per Employee
84229.46
Dividends Per Share - Security
N/A
EBITDA
-120M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.75
Revenue To Assets
-34.07
Shares Held By Institutions
666M
Shares Outstanding - Current
50.6M
Total Liabilities
364M
Total Volume MTD
N/A
Value
-1
Gain YTD
4.514
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RGNX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGNX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for RGNX
A.I. Advisor
published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com